Generate Insights with CancerLinQ Discovery®
Through CancerLinQ Discovery, we provide data and analytics to our subscribers, researchers from academia, government, health care providers, medical societies and other nonprofit organizations that can generate practical knowledge to shape the future of cancer care.
Harness Real-World Data For Quality Improvement
CancerLinQ Discovery includes curated sets of aggregated, de-identified data on a variety of cancer types across our diverse network that can be studied to uncover unseen patterns in patient characteristics and outcomes, with the goal of revealing opportunities to improve care.
in clinical trials
Data Access Toolkit
For more information about requesting data from CancerLinQ Discovery®, please download our CancerLinQ Discovery Data Access Toolkit. The toolkit includes the following:
- Data Request Form & Instructions
- Data Dictionary & FAQs
- CancerLinQ Discovery Policies
- Sample Data Use Agreement
A Community That Learns Together
CancerLinQ Discovery is building a community that learns together and shares insights to improve patient care and outcomes. In 2016, Founding Enterprise Partner AstraZeneca became the first industry strategic partner to join in the mission of CancerLinQ Discovery. Since then, CancerLinQ has established collaborations with government agencies, including the U.S. Food and Drug Administration, medical specialty societies, and other health technology companies. Interested in joining their collaborative community of learning? Email firstname.lastname@example.org